Literature DB >> 8298414

The aspirin papers.

M J Underwood, R S More.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8298414      PMCID： PMC2539221          DOI： 10.1136/bmj.308.6921.71

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  11 in total

Review 1.  The use of aspirin in ischemic heart disease.

Authors:  J E Willard; R A Lange; L D Hillis
Journal:  N Engl J Med       Date:  1992-07-16       Impact factor: 91.245

2.  Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery. A placebo-controlled, randomized study.

Authors:  T P Gavaghan; V Gebski; D W Baron
Journal:  Circulation       Date:  1991-05       Impact factor: 29.690

3.  Antiplatelet or anticoagulant therapy after coronary artery bypass surgery. A meta-analysis of clinical trials.

Authors:  W G Henderson; S Goldman; J G Copeland; T E Moritz; L A Harker
Journal:  Ann Intern Med       Date:  1989-11-01       Impact factor: 25.391

4.  Failure of antiplatelet and anticoagulant therapy to improve patency of grafts after coronary-artery bypass: a controlled, randomized study.

Authors:  G A Pantely; S H Goodnight; S H Rahimtoola; B J Harlan; H DeMots; L Calvin; J Rösch
Journal:  N Engl J Med       Date:  1979-11-01       Impact factor: 91.245

Review 5.  Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery.

Authors:  R Collins; A Scrimgeour; S Yusuf; R Peto
Journal:  N Engl J Med       Date:  1988-05-05       Impact factor: 91.245

6.  Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting. Department of Veterans Affairs Cooperative Study on Antiplatelet Therapy.

Authors:  G K Sethi; J G Copeland; S Goldman; T Moritz; K Zadina; W G Henderson
Journal:  J Am Coll Cardiol       Date:  1990-01       Impact factor: 24.094

7.  Coronary artery bypass surgery: current practice in the United Kingdom.

Authors:  G D Angelini; A J Bryan; R R West; A C Newby; I M Breckenridge
Journal:  Thorax       Date:  1989-09       Impact factor: 9.139

8.  Antiplatelet drugs in femoropopliteal vein bypasses: a multicenter trial.

Authors:  C McCollum; C Alexander; G Kenchington; P J Franks; R Greenhalgh
Journal:  J Vasc Surg       Date:  1991-01       Impact factor: 4.268

9.  Starting aspirin therapy after operation. Effects on early graft patency. Department of Veterans Affairs Cooperative Study Group.

Authors:  S Goldman; J Copeland; T Moritz; W Henderson; K Zadina; T Ovitt; K B Kern; G Sethi; G V Sharma; S Khuri
Journal:  Circulation       Date:  1991-08       Impact factor: 29.690

Review 10.  Fate of the patient with chronic leg ischaemia. A review article.

Authors:  J Dormandy; M Mahir; G Ascady; F Balsano; P De Leeuw; P Blombery; M G Bousser; D Clement; J Coffman; A Deutshinoff
Journal:  J Cardiovasc Surg (Torino)       Date:  1989 Jan-Feb       Impact factor: 1.888
View more
  5 in total

1.  Health promotion priorities for general practice: constructing and using "indicative prevalences".

Authors:  B G Charlton; N Calvert; M White; G P Rye; W Conrad; T van Zwanenberg
Journal:  BMJ       Date:  1994-04-16

2.  Aspirin use in middle-aged men with cardiovascular disease: are opportunities being missed?

Authors:  A K McCallum; P H Whincup; R W Morris; A Thomson; M Walker; S Ebrahim
Journal:  Br J Gen Pract       Date:  1997-07       Impact factor: 5.386

Review 3.  Clinical relevance of about-yearly changes in blood pressure and the environment.

Authors:  F Halberg; G Cornélissen; E Haus; G Northrup; A Portela; H Wendt; K Otsuka; Y Kumagai; Y Watanabe; R Zaslavskaya
Journal:  Int J Biometeorol       Date:  1996-11       Impact factor: 3.787

4.  Chronic Mild Hyperhomocysteinemia Alters Inflammatory and Oxidative/Nitrative Status and Causes Protein/DNA Damage, as well as Ultrastructural Changes in Cerebral Cortex: Is Acetylsalicylic Acid Neuroprotective?

Authors:  Daniella de S Moreira; Paula W Figueiró; Cassiana Siebert; Caroline A Prezzi; Francieli Rohden; Fatima C R Guma; Vanusa Manfredini; Angela T S Wyse
Journal:  Neurotox Res       Date:  2017-12-14       Impact factor: 3.911

5.  Aspirin prophylaxis for the prevention of thrombosis: expectations and limitations.

Authors:  Gundu H R Rao; Jawad Fareed
Journal:  Thrombosis       Date:  2012-02-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.